Longitudinal Brain Atrophy Patterns in Early MOG ‐Antibody Associated Disease and Relapsing Multiple Sclerosis
European Journal of Neurology · 2025
DOI: 10.1111/ene.70354 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Theodoros Ladopoulos und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, St Josef Hospital, Ruhr University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Brain, Magnetic Resonance Imaging, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Multiple Sclerosis, Relapsing-Remitting. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KKNMS, Bundesministerium für Bildung und Frauen.
Abstract (Originalsprache)
Background
Myelin oligodendrocyte glycoprotein antibody‐associated disease can manifest as a relapsing or monophasic condition. Although several MRI studies have shown evident gray and white matter atrophy compared to healthy controls, little is known about regional brain volume dynamics in myelin oligodendrocyte glycoprotein antibody‐associated disease over time.
Methods
In this study, we performed an explorative voxel‐based morphometry to detect brain volumetric differences between myelin oligodendrocyte glycoprotein antibody‐associated disease ( N = 27), relapsing multiple sclerosis ( N = 40)—both in early disease stages—and healthy controls ( N = 45). Furthermore, we investigated the longitudinal brain volume changes over a 2‐year follow‐up period in myelin oligodendrocyte glycoprotein antibody‐associated disease ( N = 15) and relapsing multiple sclerosis ( N = 40).
Results
We identified distinct patterns of regional brain volume loss in the patient subgroups compared to healthy controls. In multiple sclerosis patients, bilateral thalamic atrophy was observed, whereas patients with myelin oligodendrocyte glycoprotein antibody‐associated disease showed atrophy of the bilateral fornix and stria terminalis. Our results confirmed longitudinal volume loss in thalamic and infratentorial regions in the relapsing multiple sclerosis group, which was partly related to clinical relapses during the 2‐year follow‐up period. In contrast, no longitudinal gray or white matter changes were found in the myelin oligodendrocyte glycoprotein antibody‐associated disease group.
Conclusions
To our knowledge, this is the first MRI study demonstrating no evidence of regional brain volume loss over time in patients with myelin oligodendrocyte glycoprotein antibody‐associated disease using voxel‐based morphometry, suggesting a different—probably not progressive—pathophysiological background compared to relapsing multiple sclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, St Josef Hospital, Ruhr University Bochum, Bochum, Germany.
- Institute for Neuroradiology, St Josef Hospital, Ruhr University Bochum, Bochum, Germany.
ORCID-Profile: Theodoros Ladopoulos, Ann-Kathrin Kogel, Britta Krieger
Förderung
- KKNMS
- Bundesministerium für Bildung und Frauen
Zitieren
APA
Ladopoulos, T., Bratek, D., Schwake, C., Kogel, A. K., Bellenberg, B., Krieger, B., Abbas, Z., Gold, R., Lukas, C., Ayzenberg, I., & Schneider, R. (2025). Longitudinal Brain Atrophy Patterns in Early MOG ‐Antibody Associated Disease and Relapsing Multiple Sclerosis. European Journal of Neurology. https://doi.org/10.1111/ene.70354
Vancouver
Ladopoulos T, Bratek D, Schwake C, Kogel AK, Bellenberg B, Krieger B, et al. Longitudinal Brain Atrophy Patterns in Early MOG ‐Antibody Associated Disease and Relapsing Multiple Sclerosis. European Journal of Neurology. 2025. doi:10.1111/ene.70354
BibTeX
@article{Ladopoulos2025,
author = {Ladopoulos, Theodoros and Bratek, David and Schwake, Carolin and Kogel, Ann-Kathrin and Bellenberg, Barbara and Krieger, Britta and Abbas, Zainab and Gold, Ralf and Lukas, Carsten and Ayzenberg, Ilya and Schneider, Ruth},
title = {Longitudinal Brain Atrophy Patterns in Early MOG ‐Antibody Associated Disease and Relapsing Multiple Sclerosis},
journal = {European Journal of Neurology},
year = {2025},
doi = {10.1111/ene.70354}
}
EUVIMED